Bio-orthogonal Chemistry-Facilitated Zn-Mn Double-Layered Nanobombs Abrogate cGAS-STING Evasion of Tumor Cells.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42426950.
- Also identified by DOI 10.1002/adhm.71433.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although cGAS-STING immunotherapy holds immense potential, its efficacy is severely compromised by pathway evasion. To overcome this, we engineered a core-shell bilayer nanobomb (M/ZIF/MnO<sub>2</sub>@DBCO) via a template-assisted approach, integrating MSC1094308 into ZIF-8 cores followed by MnO<sub>2</sub> shell deposition and DBCO functionalization. In a simulated tumor microenvironment, ZIF-8 loading accelerated Mn<sup>2+</sup> release from MnO<sub>2</sub>, increasing the cumulative release by nearly 30% within 8 h compared to pristine MnO<sub>2</sub>. Cellular assays demonstrated rapid bio-orthogonal targeting of azide-modified tumors, achieving lysosomal escape within 6 h postuptake. Subsequently, MnO<sub>2</sub>-mediated glutathione (GSH) depletion and hydroxyl radical (·OH) generation, combined with Zn<sup>2+</sup> induced mitochondrial oxidative stress, produced cytotoxic reactive oxygen species (ROS) that triggered immunogenic cell death. Furthermore, Mn<sup>2+</sup>, Zn<sup>2+</sup>, and dsDNA released from damaged mitochondria cooperatively activated the cGAS-STING pathway. Concurrently, MSC1094308 inhibited ESCRT-mediated negative regulation, as evidenced by a ∼0.2 decrease in the p-STING/VPS4B-RFP colocalization coefficient, confirming the blockade of cGAS-STING evasion. In vivo studies revealed that the nanoplatform profoundly stimulated antitumor immunity, increasing tumor-infiltrating cytotoxic T lymphocytes approximately 8-fold versus untreated controls after 21 days. This work establishes an integrated strategy harnessing Zn<sup>2+</sup>/Mn<sup>2+</sup> synergy, nanobomb reactivity, and ESCRT inhibition to circumvent cGAS-STING evasion, offering a promising paradigm for cancer immunotherapy.